Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 607.1B, Johnson & Johnson(JNJ) trades at $252.20. The stock has a price-to-earnings ratio of 29.35 and currently yields dividends of 2.06%.
As of 2026-07-15, Johnson & Johnson(JNJ) stock has fluctuated between $246.00 and $256.83. The current price stands at $252.20, placing the stock +2.5% above today's low and -1.8% off the high.
The Johnson & Johnson(JNJ)'s current trading volume is 1.95M, compared to an average daily volume of 7.27M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $154.80.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $154.80.
JNJ News
Walmart vs Johnson & Johnson: Two Defensive Plays, Diverging Strategies and One Winner By Vandita Jadeja Published Jul 15, 10:00AM EDT Quick Read Walmart's eC...
Adjusted earnings rose 4.7% year over year to $2.90 per share, beating the analyst consensus estimate of $2.85. Sales increased 6.6% to $25.31 billion, ahead of...
Shares in Johnson & Johnson (JNJ) dropped about 3% early Wednesday. This came even though the U.S. pharma giant surpassed Wall Street’s sales and profit estimat...
Analyst ratings
69%
of 26 ratingsMore JNJ News
Stock futures are modestly higher, with technology shares leading premarket gains as investors shift their attention from inflation to corporate earnings. Marke...
08:54 EDT Johnson & Johnson says confident in long term projections of Medtech business Published first on TheFly – the ultimate source for real-time, market-m...
Technology Healthcare Bellwether J&J Beats And Raises, But Shares Dip Licensing Johnson & Johnson (JNJ) stock slumped early Wednesday after the healthcare giant...
Johnson & Johnson (JNJ) came out with quarterly earnings of $2.77 per share, beating the Zacks Consensus Estimate of $2.66 per share. This compares to earnings...
Johnson & Johnson (JNJ) is down ~1.8% in premarket trading Wednesday despite posting Q2 financial results that beat on both lines and revising its 2026 revenue...
Johnson & Johnson raised its forecast for the year after recording higher sales. Yves Herman / Reuters Johnson & Johnson JNJ -1.52 %decrease; down pointing tri...
Genmab (GMAB) announced that worldwide net trade sales of DARZALEX, or daratumumab, including sales of the subcutaneous, or SC, product, daratumumab and hyaluro...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.